SMTL ID : 4lly.1 (1 other biounit)

Crystal structure of Pertuzumab Clambda Fab with variable and constant domain redesigns (VRD2 and CRD2) at 1.6A

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.60 Å

Oligo State

hetero-1-1-mer

Ligands

2 x GOL: GLYCEROL(Non-functional Binders)

GOL.1: 3 residues within 4Å: Chain A: A.88, S.118, S.119 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:S.118, A:S.119, A:S.119 GOL.3: 5 residues within 4Å: Chain A: K.135, T.137, S.138 Chain B: V.116, K.205 2 PLIP interactions: 2 interactions with chain B Water bridges: B:V.116, B:T.117

1 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 4 residues within 4Å: Chain B: D.38, K.39, G.41, K.42 5 PLIP interactions: 3 interactions with chain B, 2 Ligand-Water interactions Metal complexes: B:D.38, B:K.39, B:K.42, H2O.8, H2O.9

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lewis, S.M. et al., Generation of bispecific IgG antibodies by structure-based design of an orthogonal Fab interface. Nat.Biotechnol. (2014)

Release Date

2014-01-29

Peptides

mutated Pertuzumab Fab heavy chain: A
light chain Clambda: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

mutated Pertuzumab Fab heavy chain

light chain Clambda

Related Entries With Identical Sequence